Correlation Between Cullinan Oncology and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Elevation Oncology, you can compare the effects of market volatilities on Cullinan Oncology and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Elevation Oncology.
Diversification Opportunities for Cullinan Oncology and Elevation Oncology
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cullinan and Elevation is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Elevation Oncology go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Elevation Oncology
Given the investment horizon of 90 days Cullinan Oncology LLC is expected to generate 0.62 times more return on investment than Elevation Oncology. However, Cullinan Oncology LLC is 1.6 times less risky than Elevation Oncology. It trades about -0.04 of its potential returns per unit of risk. Elevation Oncology is currently generating about -0.05 per unit of risk. If you would invest 1,870 in Cullinan Oncology LLC on November 5, 2024 and sell it today you would lose (864.00) from holding Cullinan Oncology LLC or give up 46.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cullinan Oncology LLC vs. Elevation Oncology
Performance |
| Timeline |
| Cullinan Oncology LLC |
| Elevation Oncology |
Cullinan Oncology and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cullinan Oncology and Elevation Oncology
The main advantage of trading using opposite Cullinan Oncology and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |